CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 4.55 Million USD | 16.59% |
| 2020 | 3.9 Million USD | 13.78% |
| 2019 | 3.43 Million USD | 193.13% |
| 2018 | 1.17 Million USD | 980.4% |
| 2017 | 108.38 Thousand CAD | -49.62% |
| 2016 | 215.13 Thousand CAD | -37.69% |
| 2015 | 345.29 Thousand CAD | 24.42% |
| 2014 | 277.52 Thousand CAD | 60.47% |
| 2013 | 172.94 Thousand CAD | 5.52% |
| 2012 | 163.9 Thousand CAD | -76.99% |
| 2011 | 712.34 Thousand CAD | 27.27% |
| 2010 | 559.73 Thousand CAD | 8.49% |
| 2009 | 515.95 Thousand CAD | 73.5% |
| 2008 | 297.38 Thousand CAD | -30.12% |
| 2007 | 425.58 Thousand CAD | 470.79% |
| 2006 | 74.56 Thousand CAD | -33.57% |
| 2005 | 112.23 Thousand CAD | -38.41% |
| 2004 | 182.23 Thousand CAD | 68.42% |
| 2003 | 108.2 Thousand CAD | 105.32% |
| 2002 | 52.69 Thousand CAD | 12.18% |
| 2001 | 46.97 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q2 | 4.72 Million USD | 2.14% |
| 2022 Q3 | 4.82 Million USD | 2.0% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q1 | 4.62 Million USD | 1.67% |
| 2021 Q4 | 4.55 Million USD | 2.46% |
| 2021 Q2 | 4.26 Million USD | 3.58% |
| 2021 Q1 | 4.12 Million USD | 5.5% |
| 2021 Q3 | 4.44 Million USD | 4.14% |
| 2021 FY | 4.55 Million USD | 16.59% |
| 2020 Q3 | 3.71 Million USD | 1.48% |
| 2020 Q1 | 3.57 Million USD | 4.25% |
| 2020 Q4 | 3.9 Million USD | 5.09% |
| 2020 Q2 | 3.66 Million USD | 2.34% |
| 2020 FY | 3.9 Million USD | 13.78% |
| 2019 Q3 | 2.58 Million USD | 45.98% |
| 2019 Q4 | 3.43 Million USD | 32.72% |
| 2019 FY | 3.43 Million USD | 193.13% |
| 2019 Q1 | 1.3 Million USD | 11.2% |
| 2019 Q2 | 1.77 Million USD | 36.06% |
| 2018 Q4 | 1.17 Million USD | 119.24% |
| 2018 Q1 | 118.02 Thousand CAD | 8.9% |
| 2018 Q2 | 181.34 Thousand CAD | 53.64% |
| 2018 Q3 | 534.08 Thousand CAD | 194.52% |
| 2018 FY | 1.17 Million USD | 980.4% |
| 2017 Q2 | 138.7 Thousand CAD | -12.98% |
| 2017 Q3 | 130.22 Thousand CAD | -6.12% |
| 2017 Q1 | 159.4 Thousand CAD | -25.91% |
| 2017 FY | 108.38 Thousand CAD | -49.62% |
| 2017 Q4 | 108.38 Thousand CAD | -16.77% |
| 2016 Q3 | 197.57 Thousand CAD | -52.35% |
| 2016 FY | 215.13 Thousand CAD | -37.69% |
| 2016 Q1 | 391.93 Thousand CAD | 13.51% |
| 2016 Q2 | 414.59 Thousand CAD | 5.78% |
| 2016 Q4 | 215.13 Thousand CAD | 8.89% |
| 2015 Q2 | 314.5 Thousand CAD | 11.92% |
| 2015 Q1 | 281 Thousand CAD | 1.25% |
| 2015 FY | 345.29 Thousand CAD | 24.42% |
| 2015 Q4 | 345.29 Thousand CAD | 3.69% |
| 2015 Q3 | 333 Thousand CAD | 5.88% |
| 2014 FY | 277.52 Thousand CAD | 60.47% |
| 2014 Q2 | 232.2 Thousand CAD | 18.48% |
| 2014 Q1 | 195.98 Thousand CAD | 13.32% |
| 2014 Q3 | 253.21 Thousand CAD | 9.05% |
| 2014 Q4 | 277.52 Thousand CAD | 9.6% |
| 2013 Q4 | 172.94 Thousand CAD | 15.46% |
| 2013 FY | 172.94 Thousand CAD | 5.52% |
| 2013 Q3 | 149.79 Thousand CAD | 8.36% |
| 2013 Q2 | 138.23 Thousand CAD | -7.42% |
| 2013 Q1 | 149.3 Thousand CAD | -8.91% |
| 2012 Q3 | 283.63 Thousand CAD | -63.94% |
| 2012 Q4 | 163.9 Thousand CAD | -42.21% |
| 2012 Q1 | 764.09 Thousand CAD | 7.26% |
| 2012 FY | 163.9 Thousand CAD | -76.99% |
| 2012 Q2 | 786.6 Thousand CAD | 2.95% |
| 2011 Q3 | 647.25 Thousand CAD | 1.0% |
| 2011 Q4 | 712.34 Thousand CAD | 10.06% |
| 2011 FY | 712.34 Thousand CAD | 27.27% |
| 2011 Q1 | 624.01 Thousand CAD | 11.48% |
| 2011 Q2 | 640.82 Thousand CAD | 2.69% |
| 2010 Q4 | 559.73 Thousand CAD | 0.0% |
| 2010 FY | 559.73 Thousand CAD | 8.49% |
| 2009 FY | 515.95 Thousand CAD | 73.5% |
| 2008 Q2 | 658.33 Thousand CAD | 8.05% |
| 2008 FY | 297.38 Thousand CAD | -30.12% |
| 2008 Q4 | 297.38 Thousand CAD | -36.34% |
| 2008 Q1 | 609.3 Thousand CAD | 43.17% |
| 2008 Q3 | 467.11 Thousand CAD | -29.05% |
| 2007 Q4 | 425.58 Thousand CAD | 1625.24% |
| 2007 FY | 425.58 Thousand CAD | 470.79% |
| 2007 Q1 | 74.49 Thousand CAD | -0.08% |
| 2007 Q2 | 37.51 Thousand CAD | -49.64% |
| 2007 Q3 | 24.66 Thousand CAD | -34.24% |
| 2006 Q2 | 99.75 Thousand CAD | -82.72% |
| 2006 Q4 | 74.56 Thousand CAD | -59.65% |
| 2006 FY | 74.56 Thousand CAD | -33.57% |
| 2006 Q3 | 184.78 Thousand CAD | 85.24% |
| 2006 Q1 | 577.19 Thousand CAD | 414.27% |
| 2005 Q3 | 53.86 Thousand CAD | -74.6% |
| 2005 Q4 | 112.23 Thousand CAD | 108.37% |
| 2005 Q2 | 212.07 Thousand CAD | 13.05% |
| 2005 Q1 | 187.59 Thousand CAD | 2.94% |
| 2005 FY | 112.23 Thousand CAD | -38.41% |
| 2004 Q2 | 109.91 Thousand CAD | -24.22% |
| 2004 Q3 | 135 Thousand CAD | 22.83% |
| 2004 Q4 | 182.23 Thousand CAD | 34.98% |
| 2004 FY | 182.23 Thousand CAD | 68.42% |
| 2004 Q1 | 145.04 Thousand CAD | 34.05% |
| 2003 Q3 | 99.35 Thousand CAD | 12.55% |
| 2003 Q4 | 108.2 Thousand CAD | 8.9% |
| 2003 FY | 108.2 Thousand CAD | 105.32% |
| 2003 Q1 | 70.11 Thousand CAD | 33.05% |
| 2003 Q2 | 88.27 Thousand CAD | 25.91% |
| 2002 Q2 | 23.06 Thousand CAD | 175.53% |
| 2002 FY | 52.69 Thousand CAD | 12.18% |
| 2002 Q1 | 8369.18 CAD | 0.0% |
| 2002 Q4 | 52.69 Thousand CAD | 15.44% |
| 2002 Q3 | 45.64 Thousand CAD | 97.96% |
| 2001 FY | 46.97 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 100.0% |
| BioElectronics Corporation | 16.62 Million USD | 100.0% |
| IR-Med Inc. | 634 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 100.0% |
| Polarean Imaging plc | 2.58 Million USD | 100.0% |
| AVITA Medical, Inc. | 19.86 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 100.0% |
| Össur hf. | 688.8 Million USD | 100.0% |
| Zecotek Photonics Inc. | 5.86 Million USD | 100.0% |
| QHSLab, Inc. | 2.05 Million USD | 100.0% |
| Wellstar International, Inc. | 55.99 Million USD | 100.0% |
| Össur hf. | 688.8 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 100.0% |
| Escalon Medical Corp. | 2.94 Million USD | 100.0% |
| Aurora Spine Corporation | 6.65 Million USD | 100.0% |
| BrainsWay Ltd. | 15.31 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 6.01 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 100.0% |
| Vivos Inc. | 245 Thousand USD | 100.0% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 1.01 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 100.0% |
| Nanomix Corporation | 14.81 Million USD | 100.0% |
| Theraclion SA | 13.01 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 5.12 Million USD | 100.0% |
| Positron Corporation | 2.02 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 100.0% |
| Lombard Medical, Inc. | 53.79 Million USD | 100.0% |
| ALR Technologies Inc. | 24.5 Million USD | 100.0% |
| Stratec SE | 271.97 Million USD | 100.0% |
| Vycor Medical, Inc. | 4.31 Million USD | 100.0% |
| Heart Tronics, Inc. | 1.09 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 201.36 USD | 100.0% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 100.0% |
| Ingen Technologies, Inc. | 5.7 Million USD | 100.0% |
| Odyssey Group International, Inc. | 6.61 Million USD | 100.0% |
| United American Healthcare Corporation | 119 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | 11.94 Million USD | 100.0% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 100.0% |
| Urologix, Inc. | 12.64 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 100.0% |
| SS Innovations International, Inc. | 11.18 Million USD | 100.0% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 100.0% |
| Smith & Nephew plc | 4.76 Billion USD | 100.0% |
| NIOX Group Plc | 9.8 Million USD | 100.0% |
| Fuse Medical, Inc. | 15.11 Million USD | 100.0% |
| Broncus Holding Corporation | 10.43 Million USD | 100.0% |
| Brain Scientific Inc. | 7.42 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 100.0% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 100.0% |